Clinical Trials
2 trialsNCT03384316 2020-09-09
Multi-Targeted Recombinant Ad5 (CEA/MUC1/Brachyury) Based Immunotherapy Vaccine Regimen in People With Advanced Cancer
National Institutes of Health Clinical Center (CC)
Phase 1 Completed
NCT01829373 2013-04-11
Lung Cancer Vaccine Plus Oral Dietary Supplement
University of Kentucky
Phase 1 Completed